Highlights

  • Artrya secures its second U.S. commercial customer through a three-year SaaS agreement.
  • Contract carries a minimum value of USD 0.3M with additional per-scan revenue.
  • Salix platform to be deployed across NGHS hospitals and Georgia Heart Institute network.

Artrya Limited (ASX:AYA), a medical technology company commercialising its Salix AI-powered cloud platform, has signed a three-year commercial agreement with Northeast Georgia Health System (NGHS). The deal marks Artrya’s second U.S. commercial customer and follows earlier foundation partner collaborations in the United States.

NGHS is a not-for-profit healthcare network in the U.S. Southeast, managing more than 1.6 million patient visits annually across five hospitals and a broad outpatient footprint. The Salix platform will be used by NGHS’ employed cardiology group, the Georgia Heart Institute, one of the largest cardiology programs in Georgia.

Agreement structure and revenue model
Under the commercial SaaS licence agreement, Salix Coronary Anatomy will be provided through a fixed monthly subscription over a 36-month term. The contract has a minimum value of USD 0.3M over the three years. In addition to subscription revenue, Artrya will earn fee-per-scan income from use of the Salix Coronary Plaque module in routine clinical workflows.

The agreement also includes provisions for the Salix Coronary Flow module. Once the module receives FDA clearance, NGHS will be able to activate it for clinical use, with each analysed CCTA scan generating additional fee-per-scan revenue. Both the Plaque and Flow modules are eligible for reimbursement under Category I CPT codes in the U.S.

Clinical rollout across NGHS network
Salix will be rolled out across NGHS’ hospitals, outpatient centres and physician practices within the Georgia Heart Institute. The platform will be used for patients undergoing CT coronary angiography for suspected or confirmed coronary artery disease.

Prior to signing the commercial contract, Artrya and NGHS conducted workflow validation and technical integration of the Salix Coronary Anatomy platform. This included ensuring compatibility with NGHS’ Picture Archiving and Communication System and Electronic Medical Record systems to support routine clinical use.

U.S. support and operational presence
To support the NGHS rollout and other U.S. customers, Artrya has established a Customer Success team based in Atlanta. The team will be responsible for onboarding, training, clinician engagement, system integration and ongoing technical support across customer sites.

Key contractual terms
The agreement is non-exclusive and includes standard provisions relating to data security, privacy, software upgrades and defined support levels. It runs for an initial three-year term and allows termination with 30 days’ notice without cancellation fees. Standard default provisions are also included.

Share Price Snapshot
AYA was trading 8.98% higher at AUD 3.76 per share as of 08 December 2025.